首页>外文期刊>医学、药学、卫生>JCO precision oncology.

JCO precision oncology.

中文名称：JCO精密肿瘤学。

ISSN：
出版周期：Annual

发文量：61

期刊论文

热门论文

年度选择

2022
- 第1期

更多>>

全选（0）

1.erratum

机译：勘误
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Errata;
- Breast;
- Solid TumorLung CancerPHASE STUDIESaluminium;
2.Reply to A. Rizzo et al

机译：回复A. Rizzo等人
- 作者：Jennifer Gile;Amina Jatoi;Wen Wee MaMitesh BoradNguyen H. Tran
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Fibroblast Growth Factor Receptors;
- Patients;
- aluminiumResearch Design;
3.Reply to R. Pham et al

机译：回复R. Pham等人
- 作者：Iris vant Erve;Cornells J.A. Punt;Gerrit A. MeijerRemond J.A. Fiineman
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Lung Cancer;
- Mutation;
- PancreasMetastatic Malignant Neoplasm to the Liver;
4.errata

机译：Errata
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Errata;
- bluelines;
- Lung CancerFigureBREAKSclinical outcomelegendsRed;
5.Exploring Survival Outcomes in Metastatic Colorectal Cancer Harboring KRAS A146 Mutations: Important Distinction or Simple Distraction?

机译：探索带有KRAS A146突变的转移性结直肠癌的生存结果：重要的区别或简单干扰？
- 作者：Richard Pham;Azim Jalali;Chia ChongVanessa WongKate DunnPeter Gibbs
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
6.FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary Center

机译：胆管癌中的FGFR抑制剂：三级中心的现实世界经验
- 作者：Alessro Rizzo;Giovanni Bri
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
7.Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma

机译：在微卫星不稳定性高肝外胆管癌患者中，获得了对PD-L1阻断的抗性机制
- 作者：Monica Niger;Federico Nichetti;Francesca DellAngeloVera CappellettiChiara PircherMarta VismaraChristian CotsoglouSherrie BhooriAndrea VingianiMaria Di BartolomeoFilippo PietrantonioFilippo de BraudGiancarlo PruneriMaria Grazia DaidoneVincenzo Mazzaferro
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
8.Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes

机译：IB期SEATAR研究：将rucaparib和sacituzumab Govitecan组合在癌症患者中，有或没有突变的同源重组修复基因
- 作者：Timothy A. Yap;Erika Hamilton;Todd BauerEcaterina E. DumbravaRinath JeselsohnAaron EnkeSabrina HurleyKevin K. LinJenn HabeckHeidi GiordanoGeoffrey I. Shapiro
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
9.Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mT0RC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma

机译：基于生物标志物的Sapanisertib（TAK-228）的II期研究：MT0RC1/2抑制剂在难治性转移性肾细胞癌患者中
- 作者：Bradley A. McGregor;Wanling Xie;Elio AdibWalter M. StadlerYousef ZakhariaAijai AlvaM. Dror MichaelsonShilpa GuptaElaine T. LamSubrina FarahAmin H. NassarXiao X. WeiKerry L. KilbridgeLauren HarshmanSabina SignorettiLynette ShollDavid J. KwiatkowskiRana R. McKayToni K. Choueiri
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
10.Perspectives and Experiences of Parents and Adolescents Who Participate in a Pediatric Precision Oncology Program: 'When You Feel Helpless, This Kind of Thing Is Very Helpful'

机译：参加儿科精度肿瘤学计划的父母和青少年的观点和经验：“当您感到无助时，这种事情非常有帮助”
- 作者：Larissa Waldman;Kelly Hancock;Bailey GallingerBrittney JohnstoneLedia BrungaDavid MalkinMam BarreraAnita Villani
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Adolescent;
- Parents;
- oncologyPerspectivechildhood cancerHopefulnessHelpessnessThinganticipation;
11.Real-World Experience of NTRK Fusion-Positive Thyroid Cancer

机译：NTRK融合阳性甲状腺癌的现实世界经验
- 作者：Jong Chul Park;Arya Ashok;Chienying LiuHyunseok Kang
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
12.Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review

机译：对胰腺腺癌的Olaparib和Pembrolizumab的异常反应，具有生殖线BRCA1突变和高肿瘤突变负担：病例报告和文献综述
- 作者：Joanne Lundy;Owen McKay;Daniel CroaghVinod Ganju
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
13.Phase II Study of Taselisib in PIK3CA- Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I

机译：taselisib在PIK3CA突变的实体瘤和鳞状肺癌以外的其他实体瘤的II期研究：NCI匹配的ECOG-ACRIN试验（EAY131）子协议I
- 作者：Ian E. Krop;Opeyemi A. Jegede;Juneko E. Grilley-OlsonJosh D. LauringEdith P. MitchellJames A. ZwiebelRobert J. GrayVictoria WangLisa M. McShaneLarry V. RubinsteinDavid PattonP. Mickey WilliamsStanley R. HamiltonScott A. KonoJames M. FordAgustin A. Garcia
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
14.Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers

机译：拉洛司替尼在肌动蛋白受体激酶融合阳性肺癌患者中的功效和安全性
- 作者：Alexer Drilon;Daniel S. W. Tan;Ulrik N. LassenSerge LeyvrazYongmei LiuJyoti D. PatelLee RosenBenjamin SolomonRicarda NorenbergLaura DimaNicoletta BregaLin ShenVictor MorenoShivaani KummarJessica J. Lin
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
15.Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma

机译：对BRAF THR599DUP突变黑色素瘤中BRAF和MEK抑制剂的反应
- 作者：Marion Oberle;Philippe Jamme;Srine MansardLaurent MachetAlice HervieuNora KramkimelAnna GreliakAnne Sophie JarrousseValentin DerangereDavid DudoignonClotilde DescarpentriesLaurent Mortier
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
16.Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice

机译：通过肿瘤学提供者对上皮卵巢癌的遗传测试的主流遗传测试：当前实践的调查
- 作者：Megan A. Czekalski;Rachelle C. Huziak;Andrea L. DurstSarah TaylorPhuong L. Mai
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Genetic Testing;
- Ovarian epithelial cancer;
- Referral;
17.Diagnostic and Prognostic Implications of GNAS Inactivation in Sonic Hedgehog-Activated Medulloblastoma: Case Report with Comprehensive Molecular Profiling and Review of Literature

机译：Sonic刺猬激活的髓母细胞瘤中GNA失活的诊断和预后含义：具有全面的分子分析和文献综述的病例报告
- 作者：Erin Goode;Liliana Montoya;Eric GrahamBrianna PruniskiCurtis SimmonsAlexer NgwubeLindsey M. HoffmanNishant TiwariKenneth AldapeHarper N. PriceVera PaulsonRoss Mangum
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
18.Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer

机译：早发和晚期子宫内膜癌中不同的基因组景观
- 作者：Jungyoon Choi;Andreana N. Holowatyj;Mengmeng DuZhishan ChenWanqing WenNikolaus SchultzLoren LipworthXingyi Guo
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
19.Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

机译：具有新型的Alk-Kank4基因融合的胰腺腺泡细胞癌中对抗凝激素的特殊临床反应
- 作者：Marina Gaule;Camilla Pesoni;Alberto QuinziiCamilla ZecchettoSimona CasalinoValeria MerzSerena ContarelliSilvia PietrobonoElena VissioLuca MolinaroEnrica ManzinRoberta VolpattoGiorgio VellaniDavide Melisi
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- acinar cell adenocarcinoma of the pancreas;
- Pancreatic Neoplasms;
- Gene FusionSurvival Rate;
20.Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials

机译：肿瘤学临床试验中贝叶斯信息借用方法的比较研究
- 作者：Liwen Su;Xin Chen;Jingyi ZhangFangrong Yan
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
21.Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced Gl Cancers: SCRUM-Japan GOZILA Substudy

机译：基于等离子体的基因分型对高级GL癌症中微卫星不稳定性评估的临床有效性：Scrum-Japan Gozila bestudy
- 作者：Yoshiaki Nakamura;Wataru Okamoto;Tadamichi DendaTomohiro NishinaYoshito KomatsuSatoshi YukiHisateru YasuiTaito EsakiYu SunakawaMakoto UenoEiji ShinozakiNobuhisa MatsuhashiTakashi OhtaKen Kato
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
22.PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

机译：PIK3CA突变驱动人类表皮生长因子受体2阳性乳腺癌的治疗性抗性
- 作者：Aryana R. Rasti;Amy Guimaraes-Young;Farrah DatkoVirginia F. BorgesDara L. AisnerElena Shagisultanova
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
23.Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer

机译：在治疗癌症中，RAS热点和BRAF V600E突变的相同细胞共发生
- 作者：Rodrigo Gularte-Merida;Shaleigh Smith;Anita S. BowmanArnaud da Cruz PaulaWalid ChatilaCraig M. BielskiMonika VyasLaetitia BorsuAhmet ZehirLuciano G. MartelottoJinru ShiaRona YaegerFang FangRui GardnerRuibang LuoMichael C. SchatzRonglai Shen
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
24.Identifying Outcomes of Patients With Advanced Pancreatic Adenocarcinoma and RECIST Stable Disease Using Radiomics Analysis

机译：使用放射线分析鉴定患有晚期胰腺腺癌和再生稳定疾病的患者的结局
- 作者：Qiuxia Yang;Yize Mao;Hui XieTao QinZhijun MaiQian CaiHailin WenYong LiRong ZhangLizhi Liu
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
25.Clinical Utility of Genomic Testing in Cancer Care

机译：基因组测试在癌症护理中的临床实用性
- 作者：Daryl Pritchard;Clifford Goodman;Lincoln D. Nadauld
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- cancer care;
- Genomics;
- Risks and Benefits;
26.Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy

机译：双重Trametinib和二甲双胍疗法实现的带有MEK突变和PIK3CA扩增的经常性皮肤鳞状细胞癌的持久临床反应
- 作者：Eva Remenar;Robert Doczi;Anna DirnerAnna SiposAnita PerjesiDora TihanyiBarbara VodicskaDora LakatosKatalin HorvathKornelia KajaryRichard SchwabJulia DeriCsongor Gyorgy LengyelEdit VarkondiIstvan Valyi-NagyIstvan Petak
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
27.Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of Gl Cancers: A Systematic Review

机译：围手术期无细胞DNA和循环肿瘤DNA的效用在告知GL癌的预后：系统评价
- 作者：Phillip J. Hsu;Khushboo Singh;Ankit DhimanHunter D. D. WitmerChuan HeOliver S. EngDaniel V. T. CatenacciMitchell C. PosnerKiran K. Turaga
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
28.Treatment of Disseminated Intravenous Leiomyomatosis With ALK Targeting Crizotinib: A Successful Case Report

机译：用靶向克里唑替尼的ALK治疗传播的静脉自由瘤病：成功的病例报告
- 作者：Priscila Barreto-Coelho;Andrew Rosenberg;Ty SubhawongPhilippos CostaAndrea P. Espejo-FreireSteven BialickEmily JonczakJonathan C. TrentGina Z. DAmato
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
29.Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma

机译：无循环细胞DNA捕获多管肝癌中的肿瘤内异质性
- 作者：Mairene Coto-Llerena;Andrej Benjak;John GallonMarie-Anne MeierTuyana BoldanovaLuigi M. TerraccianoCharlotte K.Y. NgSalvatore Piscuoglio
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
30.ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma

机译：ERBB2拷贝数作为对抗人类表皮生长因子受体2疗法的定量生物标志物在晚期胃食管腺癌中治疗
- 作者：Liangliang Zhang;Omar Hamdani;Ole GjoerupCheryl Cho-PhanJeremy SniderEmily CastellanosHalla NimeiriGarrett FramptonJeffrey M. VenstromGeoffrey OxnardSamuel J. KlempnerAlexa B. Schrock
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
31.Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer Types

机译：在人表皮生长因子受体2的外显子18和19中鉴定出反复插入和缺失为非小细胞肺癌和其他癌症类型的潜在驱动因素
- 作者：Yan Yin;Lijie Song;Dongsheng ShiBin LiuXiangke LiMinjie YangBihao LiuDejuan WangJianwen Qin
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
32.Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers

机译：固体癌症患者的种系药遗传学和药物相互作用的临床机会
- 作者：Tyler Shugg;Reynold C. Ly;Elizabeth J. RoweSantosh PhilipsMustafa A. HyderMilan RadovichMarc B. RosenmanVictoria M. PrattJohn T. CallaghanZeruesenay DestaBryan P. SchneiderTodd C. Skaar
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
33.Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy

机译：突变体PPM1D-和TP53驱动的造血作用可响应肽受体放射性核素治疗，造血区室
- 作者：Abhay Singh;Nuria Mencia-Trinchant;Elizabeth A. GriffithsAlaa AltahanMahesh SwaminathanMedhavi GuptaMatthew GravinaRutaba TajammalMark G. FaberLunBiao YanEti SinhaDuane C. HassaneDavid Neil HayesMonica L. GuzmanRenuka IyerEunice S. WangSwapna Thota
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
34.Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion

机译：对有丝分裂原激活的细胞外激酶抑制剂Trametinib的持续反应，该纺锤体肉瘤具有QKI-RAF1基因融合
- 作者：Francois Panet;Sungmi Jung;Thierry Alcindor
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Gene Fusion;
- Sarcoma;
- spindle cell sarcomaSpindle Cell Neoplasmphosphotransferase inhibitor;
35.Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies

机译：多发性恶性肿瘤患者中肿瘤信息和仅血浆液体活检测定
- 作者：Pashtoon Murtaza Kasi
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
36.Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study

机译：免疫检查点抑制作用作为表现超突击的同步癌的单一疗法：IRRDC研究
- 作者：Jacob J. Henderson;Anirban Das;Daniel A. MorgensternSumedha SudhamanVanessa BianchiJill ChungLogine NegmMelissa EdwardsDavid E. KramMichael OsbornCynthia HawkinsEric BouffetYoon-Jae ChoUri Tabori
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
37.Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer

机译：在癌症的OMICS强化试验中，多个转移性位点纵向分子测试的安全性，可行性和优点为MTNBC患者治疗提供了信息
- 作者：Kimberly A. Burton;Elisabeth Mahen;Eric Quentin KonnickSibel BlauMichael O. DorschnerArturo B. RamirezStephen C. SchmechelChaozhong SongRahul ParulkarStephanie ParkerFrancis Mark SenecalColin C. PritchardBrigham H. Mecham
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
38.Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

机译：具有种系碱性变体和难治性转移性神经母细胞瘤的婴儿中对肠tectectinib的持续反应，染色体2p增益和肿瘤淋巴瘤激酶和真霉素受体激酶激活
- 作者：Diana Treis;Ganesh Umapathy;Susanne FranssonJikui GuanPatricia Mendoza-GarcfaJoachim T. SiawSra WessmanLena Gordon MurkesJakob J. E. StenmanAnna DjosLotta H. M. ElfmanJohn Inge JohnsenBengt HallbergRuth H. PalmerTommy MartinssonPer Kogner
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- niobium;
- germ line;
- Tropomyosinsdisseminated neuroblastomapoor prognosis;
39.Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers

机译：极点突变的临床和分子表征是晚期癌症中对免疫检查点抑制剂反应的预测生物标志物
- 作者：Benjamin Garmezy;Jinesh Gheeya;Heather Y. LinYuefan HuangTaebeom KimXianli JiangKyaw Z. TheinPatrick G. PilieFadl ZeineddineWanlin WangKenna R. ShawJordi RodonJohn Paul ShenYing YuanFunda Meric-BernstamKen ChenTimothy A. Yap
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
40.Case of Metastatic Pheochromocytoma and Meningiomas in a Patient With Lynch Syndrome

机译：林奇综合征患者的转移性嗜铬细胞瘤和脑膜瘤病例
- 作者：Meryl D. Colton;Kenneth Tompkins;Emily ODonnellDara AisnerChristopher H. LieuEric Q. KonnickLauren Fishbein
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
41.Lymphomatous Meningitis From Anaplastic Lymphoma Kinase+ Anaplastic Large T-Cell Lymphoma Treated With Lorlatinib: A Case Report

机译：从劳拉替尼治疗的肿瘤淋巴瘤激酶+仿生大型大型T细胞淋巴瘤的淋巴瘤脑膜炎：病例报告
- 作者：Smitha Mellacheruvu;Mark N. Sayegh;R. Alejro SicaHaiying ChengMaria Laureana Santos-ZabalaJacob H. GebraelUlrich HermantoNorman L. Rosen
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Anaplastic Large-Cell Lymphoma;
- CD30 Antigens;
- adult non-Hodgkin's lymphomaCase Reports;
42.Landscape of KRAS~G12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

机译：KRAS〜G12C的景观，相关的基因组改变和与免疫肿瘤生物标志物的相互关系
- 作者：Mohamed E. Salem;Sherif M. El-Refai;Wei ShaAlberto PucciniAxel GrotheyThomas J. GeorgeJimmy J. HwangBert ONeilAlexer S. BarrettKunal C. KadakiaLaura W. MusselwhiteDerek RaghavanEric Van CutsemJosep TaberneroJeanne Tie
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
43.Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts

机译：用患者衍生的异种移植物定义和靶向食管胃癌基因组子集
- 作者：Ryan H. Moy;Henry S. Walch;Marissa MattarWalid K. ChatilaDaniela MolenaVivian E. StrongLaura H. TangSteven B. MaronDaniel G. CoitDavid R. JonesJaclyn F. HechtmanDavid B. SolitNikolaus SchultzElisa de StanchinaYelena Y. Janjigian
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
44.Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer

机译：过度热腹膜化疗诱导的人类分子变化验证了卵巢癌的临床前数据
- 作者：Thanh H. Dellinger;Ernest S. Han;Mustafa RaoofByrne LeeXiwei WuHyejin ChoTing-Fang HePeter LeeMarianne RazaviWinnie S. LiangDaniel SchmolzeSaul J. PricemanStephen LeeWei-Chien LinJeff F. LinMehdi KebriaAmy HakimNora Ruel
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
45.Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort

机译：在大型学术医学中心队列中，现实世界中使用分子靶向疗法的标签分析分析
- 作者：Vivek A. Upadhyay;Bruce E. Johnson;Adam B. LmanMichael J. Hassett
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Molecular Targeted Therapy;
- Off-Label Use;
- Cohort StudiesPatientsSolid TumorSurvival;
46.Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges

机译：肉瘤中CDK4/6抑制剂的临床实用性：成功和未来挑战
- 作者：Jocelyn Y. Hsu;Nathan D. Seligson;John L. HaysWayne O. MilesJames L. Chen
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Sarcoma;
- United States National Institutes of Health;
47.Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center

机译：佐治亚州癌症中心的ASCO/美国病理学家指南的有效性1％激素受体阳性截止
- 作者：Firas Kreidieh;Ramses F. Sadek;Li Fang ZhangAaron GopalJean-Pierre BlaizeDavid YasharReena PatelHiral S. PatelShou-Ching TangHoussein Abdul Sater
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- cancer center;
48.Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

机译：通过自动电泳评估评估的无血浆DNA完整性预测了乳腺癌患者对新辅助化疗的病理完全反应
- 作者：Gabriella Cirmena;Lorenzo Ferro;Francesco RaveraAnna GarutiMartina DameriMaurizio GalloValentina BarberoFabio FerroLucia Del MastroAlessro GarlaschiDaniele FriedmanPiero FregattiAlberto BallestreroGabriele Zoppoli
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
49.Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors

机译：监测用异氯酸酯脱氢酶抑制剂治疗的IDH突破性胆管癌患者的循环肿瘤DNA中的动态变化和克隆进化。
- 作者：Morten Lapin;Helen J. Huang;Sharmeen ChaganiMilind JavleRachna T. ShroffShubham PantMohamed A. GoudaAnjali RainaKiran MadwaniVeronica R. HolleyS. Greg CallDerek J. DustinRichard B. LanmanFunda Meric-BernstamVictoria M. RaymondLawrence N. KwongFilip Janku
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
50.Apolipoprotem B mRNA-Editmg Catalytic Polypeptide-Like-lnduced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression

机译：雌激素受体阳性，人表皮生长因子受体2阴性乳腺癌在整个疾病进展中
- 作者：Manouk K. Bos;Marcel Smid;Stefan SleijferJohn W. M. Martens
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
51.Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors

机译：基于肿瘤DNA的分子残留疾病检测对实体瘤的临床试验的行为和设计的影响
- 作者：Pashtoon M. Kasi;Gordon Fehringer;Hiroya TaniguchiNaureen StarlingYoshiaki NakamuraDaisuke KotaniThomas PowlesBob T. LiLajos PusztaiVasily N. AushevEkaterina KalashnikovaShruti SharmaMeenakshi MalhotraZachary P. Demko
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
52.PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer

机译：PTEN损失和BRCA1启动子高甲基化对BRCA缺陷型卵巢癌的免疫原性有负预测
- 作者：Adam A. Kraya;Kara N. Maxwell;Monika A. EivaBradley WubbenhorstJohn PlutaMichael FeldmanAnupma NayakDaniel J. Powell JrSusan M. DomchekRobert H. VonderheideKatherine L. Nathanson
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- immunogenicity;
- Ovary Cancer;
- genomic featuresgerm lineCancerBRCA1 ProteinHypermethylation;
53.Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical Outcomes

机译：异氯酸酯脱氢酶氧化胆管癌：自然史和临床结果
- 作者：Grant Wintheiser;Tyler Zemla;Qian ShiNguyen TranKritika PrasaiSri Harsha TeliaKabir ModyDaniel AhnMitesh BoradTanios Bekaii-SaabAmit Mahipal
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
54.Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes

机译：依赖细胞周期蛋白的激酶4/6抑制剂在晚期乳腺癌患者中携带种系致病性变异的患者DNA修复相关基因
- 作者：Luisina Bruno;Alexis Ostinelli;Federico WaisbergDiego EnricoCarolina PonceSergio RiveroAlbano BlancoMartfn ZarbaMartfn LozaVeronica FabianoMora AmatMarfa Teresa PomboLaura NoroMatfas ChaconFederico ColoReinaldo ChaconJorge NadalAdrian NervoVictoria Costanzo
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
55.Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

机译：循环T细胞库与接受新辅助化疗的乳腺癌患者的肿瘤反应相关
- 作者：Gengxi Cai;Zhanwen Guan;Yabin JinZuhui SuXiangping ChenQing LiuChunlin WangXiaoxia YinLifang ZhangGuolin YeWei Luo
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Breast Cancer;
- T-Lymphocytes;
- Adjuvant ChemotherapyReceptor, ErbB-2PatientsTumours;
56.A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone- Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to Darolutamide

机译：前列腺癌具有雄激素受体T878A孕酮 - 乙酸阿比罗酮治疗后出现的反应性突变体对Darolutamide响应
- 作者：Andreas Varkaris;Julia Stevens;Yuho OnoSteven P. BalkJoaquim Bellmunt
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
57.Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast Cancer

机译：分子生物标志物的系统评价可预测转移性乳腺癌中对CDK4/6的抑制作用
- 作者：Uzma S. Asghar;Ruhi Kanani;Rebecca RoylanceSibylle Mittnacht
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
58.Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine

机译：来自分子肿瘤板的现实世界数据：乳房和妇科癌症患者的预后改善
- 作者：Lindsey M. Charo;Ramez N. Esker;Jason SicklickKi Hwan KimHyo Jeong LimRyosuke OkamuraSuzanna LeeRupa SubramanianRichard SchwabRebecca ShatskySteven PlaxeShumei KatoRazelle Kurzrock
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Otolaryngologists;
- Breast;
- ComplianceBreast CancerTumoursCancer;
59.Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing

机译：使用RNA测序改善了儿童癌症诊断的基因融合检测
- 作者：Jayne Y. Hehir-Kwa;Marco J. Koudijs;Eugene T. P. VerwielLennart A. KesterMarc van TuilEric StrengmanArjan BuijsMariette E. G. KranendonkLaura S. Hiemcke-JiwaValerie de HaasEllen van de GeerWendy de LengJasper van der LugtPhilip LijnzaadFrank C. P. HolstegePatrick KemmerenBastiaan B. J. Tops
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
- Gene Fusion;
- RNA Sequence;
- Analyses, Sequencechildhood cancerdiagnostic techniques;
60.Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma

机译：尿液3-甲氧基酰胺是神经母细胞瘤患者MYC活性的生物标志物
- 作者：ledan R. N. Verly;Yvette A. H. Matser;Rene LeenRutger MeinsmaMarta FioccoJan KosterRichard VolckmannDilara Savci-HeijinkGiuliana CangemiSebastiano BarcoLinda J. ValentijnGodelieve A. M. TytgatAndre B. P. van Kuilenburg
- 期刊名称：《JCO precision oncology.》 | 2022年第1期
61.Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy

机译：新辅助全身化疗后没有病理完全反应的患者三阴性乳腺癌分子亚型的变化
- 作者：Hiroko Masuda;Kenichi Harano;Sakiko MiuraYing WangYuko HirotaOi HaradaMohit Kumar JollyYuki MatsunagaBora LimAnita L. WoodNapa ParinyanitikulHee Jin LeeGyungyub GongJason T. GeorgeHerbert Levine
- 期刊名称：《JCO precision oncology.》 | 2022年第1期

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号